At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 138 enrolled
Drug / intervention
Pecans +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cardiometabolic Effects of Including Pecans as a Snack to Improve Diet Quality: a Randomized Controlled Study
In Brief
A Phase 2 clinical trial evaluating Pecans and Usual Care for Cardiovascular Diseases. Completed, enrolled 138 participants across 1 site.
Detailed Summary
A randomized, 2-arm, parallel trial will be conducted to examine the effect of pecans on markers of peripheral vascular health, lipids and lipoproteins, blood pressure, and glycemic control.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases
CountriesUnited States
CollaboratorsAmerican Pecan Council
Timeline
Phase 2CompletedFinished
20222023202420252026
First PostedOct 2021
Enrollment StartAug 2022
Primary CompletionMar 2024
TodayJul 2026
First PostedOct 8, 2021
Enrollment StartAug 15, 2022
Primary CompletionMar 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.7 years ago
Interventions
Pecansdrug
Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Careother
Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.